Literature DB >> 10399179

Immunohistochemical and histochemical characterization of the mucosubstances of odontogenic myxoma: histogenesis and differential diagnosis.

M Zhao1, Y Lu, T Takata, I Ogawa, M Miyauchi, D Mock, H Nikai.   

Abstract

To discuss the dental origin of odontogenic myxoma and to provide further information for the differential diagnosis between this tumor and myxoid malignant fibrous histiocytoma (MFH) which occasionally occurs in jaw bones, the contents of glycosaminoglycans (GAGs) and proteoglycans (PGs) in the mucosubstances of 15 odontogenic myxomas, 5 myxoid MFH and 3 human fetal tooth germs in the bell stage of development were characterized using histochemical and immunohistochemical methods. Histochemical staining of hyaluronic acid (HA) was undertaken using biotinylated HA binding protein (B-HABP), and immunohistochemical detection was done using a panel of antibodies against chondroitin 6-sulfate (CS-6), chondroitin 4-sulfate (CS-4), dermatan sulfate (DS), keratan sulfate (KS), heparan sulfate (HS), aggrecan, PG-M/versican, decorin and biglycan. In odontogenic myxoma, CS-6, HA and PG-M/versican were observed in the myxomatous matrix of all cases, while KS and HS were seen in none. As for CS-4, DS, aggrecan, decorin and biglycan, only irregular and mild stainings were shown. Consistent and strong positive straining for CS-6, HA and PG-M/versican were seen in dental papilla and provided evidence supporting the origin of this tumor from dental papilla. Except for the constant staining for HA, the myxoid matrix was rarely stained for most GAGs and PGs in myxoid MFH. Immunodetection of CS-6 and PG-M/version with the use of monoclonal antibodies 3-B-3 and 2-B-1 is therefore recommended as a useful tool in differentiating odontogenic myoma from myxoid MFH.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10399179     DOI: 10.1016/S0344-0338(99)80012-0

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  7 in total

1.  Nestin expression in odontoblasts and odontogenic ectomesenchymal tissue of odontogenic tumours.

Authors:  S Fujita; K Hideshima; T Ikeda
Journal:  J Clin Pathol       Date:  2006-03       Impact factor: 3.411

2.  Biglycan stimulates VEGF expression in endothelial cells by activating the TLR signaling pathway.

Authors:  Lei Hu; Ming-de Zang; He-Xiao Wang; Jian-Fang Li; Li-Ping Su; Min Yan; Chen Li; Qiu-Meng Yang; Bing-Ya Liu; Zheng-Gang Zhu
Journal:  Mol Oncol       Date:  2016-08-24       Impact factor: 6.603

Review 3.  Running GAGs: myxoid matrix in tumor pathology revisited: what's in it for the pathologist?

Authors:  Stefan M Willems; Malgorzata Wiweger; J Frans Graadt van Roggen; Pancras C W Hogendoorn
Journal:  Virchows Arch       Date:  2009-08-25       Impact factor: 4.064

Review 4.  Odontogenic myxoma with diffuse calcifications: a case report and review of the literature.

Authors:  Edward Lahey; Sook-Bin Woo; Hee-Kyung Park
Journal:  Head Neck Pathol       Date:  2012-07-27

5.  Odontogenic myxoma of the maxilla: A report of a rare case and review on histogenetic and diagnostic concepts.

Authors:  Ajaz Shah; Parveen Lone; Suhail Latoo; Irshad Ahmed; Altaf Malik; Shahid Hassan; Aijaz Naik; Rizwan Ur Rashid
Journal:  Natl J Maxillofac Surg       Date:  2011-07

Review 6.  Proteoglycans as potential biomarkers in odontogenic tumors.

Authors:  Zaira Gómez-Herrera; Nelly Molina-Frechero; Pablo Damián-Matsumura; Ronell Bologna-Molina
Journal:  J Oral Maxillofac Pathol       Date:  2018 Jan-Apr

7.  Odontogenic myxoma: ambiguous pathology of anterior maxilla.

Authors:  Suman Bisla; Ambika Gupta; Anjali Narwal; Virendra Singh
Journal:  BMJ Case Rep       Date:  2020-08-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.